Presentation is loading. Please wait.

Presentation is loading. Please wait.

IAS 2017 PARIS July 23rd, 2017.

Published byCornelius Briggs Modified over 5 years ago

Similar presentations

Presentation on theme: "IAS 2017 PARIS July 23rd, 2017."— Presentation transcript:

1 IAS 2017 PARIS July 23rd, 2017

2 IAS 2017 PARIS July 23rd, 2017

3 Future Perfect : Opportunities and Obstacles for HIV Vaccines
Program Anthony Fauci; An HIV vaccine: Can we end the HIV pandemic without one and, if not, how do we get one? Louis Picker; Exploiting novel cellular immunity in HIV prevention: Development of a prophylactic HIV vaccine based on Cytomegalovirus (CMV) vectors. Rogier Sanders; Novel envelope proteins to induce neutralizing antibodies. Panel discussion moderated by Robin Shattock, Imperial College London, with : Jon Cohen, Science Maureen Goodenow, Office of AIDS Research Yves Levy, INSERM Nyaradzo M. Mgodi, University of Zimbabwe Nina Russell, Bill & Melinda Gates Foundation Hanneke Schuitemaker, Janssen Vaccines & Prevention

4

5 IAS 2017 PARIS July 23rd, 2017

6

Download ppt "IAS 2017 PARIS July 23rd, 2017."

Similar presentations

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation Male Circumcision funding Heather Harrison WHO meeting June, 2010.

Bill & Melinda Gates Foundation Male Circumcision funding Heather Harrison WHO meeting June, 2010.
Carl W. Dieffenbach, Ph.D. Director Division of AIDS, NIAID July 2, 2013 HIV Vaccine and Future Strategies.

Carl W. Dieffenbach, Ph.D. Director Division of AIDS, NIAID July 2, 2013 HIV Vaccine and Future Strategies.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.

Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?

Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?
TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004.

TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004.
1 HIV Curative Strategies: Key Research Priorities Deeks S, et al., (2013) Nat Rev Immunol. 12(8): 607-614.

1 HIV Curative Strategies: Key Research Priorities Deeks S, et al., (2013) Nat Rev Immunol. 12(8):
Partnerships in Promoting Innovation and Managing Risk Scientific and Financial Innovation in AIDS Vaccines International AIDS Vaccine Initiative Labeeb.

Partnerships in Promoting Innovation and Managing Risk Scientific and Financial Innovation in AIDS Vaccines International AIDS Vaccine Initiative Labeeb.
18.3 Viral Diseases KEY CONCEPT Some viral diseases can be prevented with vaccines.

18.3 Viral Diseases KEY CONCEPT Some viral diseases can be prevented with vaccines.
Better Science with Sex and gender in mind Shifting the paradigm in HIV research XIX IAC Washington DC 23 July 2012 18:30 – 20:30 Dr. Shirin Heidari, IAS-ILF.

Better Science with Sex and gender in mind Shifting the paradigm in HIV research XIX IAC Washington DC 23 July :30 – 20:30 Dr. Shirin Heidari, IAS-ILF.
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
OFFICE OF AIDS RESEARCH DHHS/NIH/OAR NIH AIDS Research Priorities Jack Whitescarver, Ph.D. NIH Associate Director for AIDS Research and Director, OAR May.

OFFICE OF AIDS RESEARCH DHHS/NIH/OAR NIH AIDS Research Priorities Jack Whitescarver, Ph.D. NIH Associate Director for AIDS Research and Director, OAR May.
Bill Gates Bill Gates a man who changed the world. By: Anthony Ferreira, Bryan Villatoro Leonard Velverde Malcolm Ducasse.

Bill Gates Bill Gates a man who changed the world. By: Anthony Ferreira, Bryan Villatoro Leonard Velverde Malcolm Ducasse.
MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT.

MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT.
International AIDS Vaccine Initiative UK CAB May 21, 2004 Maite Suárez, European Country Programmes Officer.

International AIDS Vaccine Initiative UK CAB May 21, 2004 Maite Suárez, European Country Programmes Officer.
Myron S. Cohen, MD Associate Vice Chancellor Director, Institute for Global Health The University of North Carolina.

Myron S. Cohen, MD Associate Vice Chancellor Director, Institute for Global Health The University of North Carolina.
Bill Gates Microsoft founder By: Corina Frink. 0 He likes to donate a lot of his money to charities and to help organizations 0 He is the world’s leading.

Bill Gates Microsoft founder By: Corina Frink. 0 He likes to donate a lot of his money to charities and to help organizations 0 He is the world’s leading.
Bill Gates Bill Gates a man who changed the world. By: Anthony Ferreira, Bryan Villatoro Leonard Velverde Malcolm Ducasse.

Bill Gates Bill Gates a man who changed the world. By: Anthony Ferreira, Bryan Villatoro Leonard Velverde Malcolm Ducasse.
Why Do We Need To Understand the Structure of Viruses and How they Replicate? http://www.youtube.com/watch?v=kiG-c964ejQ&NR=1.

Why Do We Need To Understand the Structure of Viruses and How they Replicate?
Mr. Bombick 7th Grade Science

Mr. Bombick 7th Grade Science

Similar presentations

Ads by Google